U.S. markets closed

Brooks Automation, Inc. (BRKS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
103.45+2.31 (+2.28%)
At close: 4:00PM EDT
103.10 -0.35 (-0.34%)
After hours: 06:51PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close101.14
Bid103.10 x 1200
Ask105.00 x 900
Day's Range101.44 - 103.92
52 Week Range46.22 - 110.40
Avg. Volume594,642
Market Cap7.686B
Beta (5Y Monthly)1.78
PE Ratio (TTM)65.31
EPS (TTM)1.58
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & Yield0.40 (0.39%)
Ex-Dividend DateSep 02, 2021
1y Target Est116.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-16% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BRKS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Brooks Automation, Inc.
    BRKS: Lowering target price to $107.00BROOKS AUTOMATION INC has an Investment Rating of HOLD; a target price of $107.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • PR Newswire

    Brooks Automation Announces Transition and Departure Plans of Dr. Amy Liao

    Brooks Automation, Inc. (Nasdaq: BRKS) announced today that Dr. Amy Liao, President of Life Sciences Services, will be transitioning into the role of strategic advisor to the CEO until the end of this calendar year, at which time she will leave the Company to pursue other interests. During this transition, Dr. Liao will be advising on the Company's growth initiatives and continued promotion of the newly formed standalone life sciences business, Azenta Life Sciences.

  • Zacks

    Zacks Industry Outlook Highlights: Entegris, Brooks Automation and Nikon

    Zacks Industry Outlook Highlights: Entegris, Brooks Automation and Nikon

  • PR Newswire

    Brooks Automation and Cleveland Clinic Celebrate Opening of Biobanking Facility

    Brooks Automation, Inc. (Nasdaq: BRKS) and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic's main campus. The two-story biorepository is managed by Azenta Life Sciences, Brooks' recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The new facility increases biobanking capacity at Cleveland Clinic and will help accelerate